Cytotoxic and Apoptotic Effects of the Combination of Borax (Sodium Tetraborate) and 5-Fluorouracil on DLD-1 Human Colorectal Adenocarcinoma Cell Line. 2022

Ömer Faruk Kırlangıç, and Ecem Kaya-Sezginer, and Sema Ören, and Serap Gür, and Özlem Yavuz, and Taner Özgürtaş
Gazi University, Faculty of Medicine, Department of Medical Biochemistry, Ankara, Türkiye.

Colorectal cancer (CRC) remains a crucial health problem due to the toxicity of 5-Fluorouracil (5-FU) as first-line chemotherapy agent for treating CRC. The anticancer effects of boron and its compounds have been shown in various cell lines. This study aimed to examine the cytotoxic and apoptotic effects of borax (sodium tetraborate) alone or along with 5-FU on human CRC cells, DLD-1. Cytotoxicity and apoptosis were determined by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay, 4',6-diamidino-2-phenylindole and annexin V/propidium iodide staining. The results showed that combined treatment revealed a significant time- and concentration-dependent cytotoxic effect on DLD-1 cells compared with borax or 5-FU treatment alone. The combination of borax and 5-FU induced a clear increase in the early apoptotic cell percentage, compared to the cells treated with monotherapies. Additionally, a significant increase in condensed and fragmented nuclei was detected in DLD-1 cells treated with the combination treatment compared with borax or 5-FU alone. Our current findings suggest that the combination of borax with 5-FU has a strong cytotoxic and apoptotic effect on the human CRC DLD-1 cells.

UI MeSH Term Description Entries

Related Publications

Ömer Faruk Kırlangıç, and Ecem Kaya-Sezginer, and Sema Ören, and Serap Gür, and Özlem Yavuz, and Taner Özgürtaş
April 2015, Pathology oncology research : POR,
Ömer Faruk Kırlangıç, and Ecem Kaya-Sezginer, and Sema Ören, and Serap Gür, and Özlem Yavuz, and Taner Özgürtaş
February 1984, International journal of oral surgery,
Ömer Faruk Kırlangıç, and Ecem Kaya-Sezginer, and Sema Ören, and Serap Gür, and Özlem Yavuz, and Taner Özgürtaş
April 2024, Molecular biology reports,
Ömer Faruk Kırlangıç, and Ecem Kaya-Sezginer, and Sema Ören, and Serap Gür, and Özlem Yavuz, and Taner Özgürtaş
August 1986, European journal of cancer & clinical oncology,
Ömer Faruk Kırlangıç, and Ecem Kaya-Sezginer, and Sema Ören, and Serap Gür, and Özlem Yavuz, and Taner Özgürtaş
May 2024, Molecular biology reports,
Ömer Faruk Kırlangıç, and Ecem Kaya-Sezginer, and Sema Ören, and Serap Gür, and Özlem Yavuz, and Taner Özgürtaş
July 2004, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
Ömer Faruk Kırlangıç, and Ecem Kaya-Sezginer, and Sema Ören, and Serap Gür, and Özlem Yavuz, and Taner Özgürtaş
July 2002, Chinese medical journal,
Ömer Faruk Kırlangıç, and Ecem Kaya-Sezginer, and Sema Ören, and Serap Gür, and Özlem Yavuz, and Taner Özgürtaş
January 2021, Iranian journal of pharmaceutical research : IJPR,
Ömer Faruk Kırlangıç, and Ecem Kaya-Sezginer, and Sema Ören, and Serap Gür, and Özlem Yavuz, and Taner Özgürtaş
September 1983, Cancer research,
Ömer Faruk Kırlangıç, and Ecem Kaya-Sezginer, and Sema Ören, and Serap Gür, and Özlem Yavuz, and Taner Özgürtaş
October 2016, Genetics and molecular research : GMR,
Copied contents to your clipboard!